Sign up to save your podcasts
Or
Share Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks.
Show reference:
https://www.neurology.org/doi/10.1212/NXI.0000000000200211
View all episodes
By American Academy of Neurology
4.8
132132 ratings
Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks.
Show reference:
https://www.neurology.org/doi/10.1212/NXI.0000000000200211
More shows like Neurology Minute
View all
NEJM This Week
317 Listeners
JAMA Clinical Reviews
498 Listeners
Neurology® Podcast
299 Listeners
Practical Neurology Podcast
50 Listeners
Mayo Clinic Talks
298 Listeners
The Curbsiders Internal Medicine Podcast
3,347 Listeners
JAMA Neurology Author Interviews
12 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
195 Listeners
JAMA Medical News
92 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Neurology Exam Prep Podcast
188 Listeners
Continuum Audio
80 Listeners